220 related articles for article (PubMed ID: 19151754)
1. E-cadherin directly contributes to PI3K/AKT activation by engaging the PI3K-p85 regulatory subunit to adherens junctions of ovarian carcinoma cells.
De Santis G; Miotti S; Mazzi M; Canevari S; Tomassetti A
Oncogene; 2009 Mar; 28(9):1206-17. PubMed ID: 19151754
[TBL] [Abstract][Full Text] [Related]
2. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin increases squamous cell carcinoma antigen expression through phosphatidylinositol-3 kinase-Akt pathway in squamous cell carcinoma cell lines.
Nakagawa T; Murakami A; Torii M; Nawata S; Takeda O; Sugino N
Oncol Rep; 2007 Jul; 18(1):175-9. PubMed ID: 17549365
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of MEK/ERK signaling by E-cadherin-dependent PI3K/Akt pathway in differentiating intestinal epithelial cells.
Laprise P; Langlois MJ; Boucher MJ; Jobin C; Rivard N
J Cell Physiol; 2004 Apr; 199(1):32-9. PubMed ID: 14978732
[TBL] [Abstract][Full Text] [Related]
5. Lebectin increases N-cadherin-mediated adhesion through PI3K/AKT pathway.
Sarray S; Siret C; Lehmann M; Marrakchi N; Luis J; El Ayeb M; André F
Cancer Lett; 2009 Nov; 285(2):174-81. PubMed ID: 19501458
[TBL] [Abstract][Full Text] [Related]
6. Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.
Huang Y; Hua K; Zhou X; Jin H; Chen X; Lu X; Yu Y; Zha X; Feng Y
Cell Res; 2008 Jul; 18(7):780-91. PubMed ID: 18574502
[TBL] [Abstract][Full Text] [Related]
7. The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression.
Wu C; Cipollone J; Maines-Bandiera S; Tan C; Karsan A; Auersperg N; Roskelley CD
Differentiation; 2008 Feb; 76(2):193-205. PubMed ID: 17608733
[TBL] [Abstract][Full Text] [Related]
8. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways.
Larue L; Bellacosa A
Oncogene; 2005 Nov; 24(50):7443-54. PubMed ID: 16288291
[TBL] [Abstract][Full Text] [Related]
9. Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer.
Hua K; Feng W; Cao Q; Zhou X; Lu X; Feng Y
Int J Oncol; 2008 Nov; 33(5):959-67. PubMed ID: 18949358
[TBL] [Abstract][Full Text] [Related]
10. Aberration of the PI3K/AKT/mTOR signaling in epithelial ovarian cancer and its implication in cisplatin-based chemotherapy.
Zhang HY; Zhang PN; Sun H
Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):81-6. PubMed ID: 19540648
[TBL] [Abstract][Full Text] [Related]
11. N-glycosylation affects the adhesive function of E-Cadherin through modifying the composition of adherens junctions (AJs) in human breast carcinoma cell line MDA-MB-435.
Zhao H; Liang Y; Xu Z; Wang L; Zhou F; Li Z; Jin J; Yang Y; Fang Z; Hu Y; Zhang L; Su J; Zha X
J Cell Biochem; 2008 May; 104(1):162-75. PubMed ID: 17979184
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of PI3K/Akt partially leads to the inhibition of PrP(C)-induced drug resistance in gastric cancer cells.
Liang J; Ge F; Guo C; Luo G; Wang X; Han G; Zhang D; Wang J; Li K; Pan Y; Yao L; Yin Z; Guo X; Wu K; Ding J; Fan D
FEBS J; 2009 Feb; 276(3):685-94. PubMed ID: 19143835
[TBL] [Abstract][Full Text] [Related]
13. RhoA mediates cyclooxygenase-2 signaling to disrupt the formation of adherens junctions and increase cell motility.
Chang YW; Marlin JW; Chance TW; Jakobi R
Cancer Res; 2006 Dec; 66(24):11700-8. PubMed ID: 17178865
[TBL] [Abstract][Full Text] [Related]
14. Thyroid-hormone-dependent activation of the phosphoinositide 3-kinase/Akt cascade requires Src and enhances neuronal survival.
Cao X; Kambe F; Yamauchi M; Seo H
Biochem J; 2009 Nov; 424(2):201-9. PubMed ID: 19747164
[TBL] [Abstract][Full Text] [Related]
15. Growth-suppressing function of glypican-3 (GPC3) via insulin like growth factor II (IGF-II) signaling pathway in ovarian clear cell carcinoma cells.
Sakurai M; Shibata K; Umezu T; Kajiyama H; Yamamoto E; Ino K; Nawa A; Kikkawa F
Gynecol Oncol; 2010 Nov; 119(2):332-6. PubMed ID: 20701957
[TBL] [Abstract][Full Text] [Related]
16. beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells.
Nygren MK; Døsen-Dahl G; Stubberud H; Wälchli S; Munthe E; Rian E
Exp Hematol; 2009 Feb; 37(2):225-33. PubMed ID: 19101069
[TBL] [Abstract][Full Text] [Related]
17. Dephosphorylation of Akt in C6 cells grown in serum-free conditions corresponds with redistribution of p85/PI3K to the nucleus.
Sephton CF; Mousseau DD
J Neurosci Res; 2008 Feb; 86(3):675-82. PubMed ID: 17918740
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis.
Tang C; Lu YH; Xie JH; Wang F; Zou JN; Yang JS; Xing YY; Xi T
Anticancer Drugs; 2009 Apr; 20(4):249-58. PubMed ID: 19174695
[TBL] [Abstract][Full Text] [Related]
19. The phosphoinositide 3-kinase/Akt pathway is essential for the retinoic acid-induced differentiation of F9 cells.
Bastien J; Plassat JL; Payrastre B; Rochette-Egly C
Oncogene; 2006 Mar; 25(14):2040-7. PubMed ID: 16288212
[TBL] [Abstract][Full Text] [Related]
20. Cell adhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells.
Shtutman M; Levina E; Ohouo P; Baig M; Roninson IB
Cancer Res; 2006 Dec; 66(23):11370-80. PubMed ID: 17145883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
